Status:

COMPLETED

A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

HIV Infections

Eligibility:

All Genders

3-16 years

Phase:

PHASE2

Brief Summary

The purpose of this study is to determine the safety and effectiveness of a soft-gel capsule formulation of saquinavir (SQV-SGC), a protease inhibitor, when given in combination with other anti-HIV dr...

Detailed Description

Clinical trials in adults and children suggest that SQV-SGC has advantages over other protease inhibitors in terms of tolerability, safety, and effectiveness in patients who have failed therapy with o...

Eligibility Criteria

Inclusion Criteria

Your child may be eligible for this study if he or she:

  • Is HIV-positive.
  • Is 3 to 16 years of age (consent of parent or guardian is required).
  • Has an HIV level greater than 10,000 copies/ml.
  • Has never taken at least one of the following anti-HIV drugs: lamivudine, zidovudine, stavudine, or didanosine.
  • Is able to swallow capsules and tablets.

Exclusion Criteria

Your child will not be eligible if he or she:

  • Has cancer requiring chemotherapy.
  • Has an acute opportunistic (AIDS-related) infection requiring therapy.
  • Has had two or more episodes of moderate or severe diarrhea or vomiting in the 3 months prior to study entry.
  • Has ever taken SQV or NFV.
  • Is pregnant or breast-feeding.
  • Is taking certain medications, including those that would interfere with the study drugs.

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

End Date :

April 1 2001

Estimated Enrollment :

50 Patients enrolled

Trial Details

Trial ID

NCT00000913

End Date

April 1 2001

Last Update

October 29 2021

Active Locations (36)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 9 (36 locations)

1

Univ of Alabama at Birmingham / Childrens Hosp of AL

Birmingham, Alabama, United States, 352330011

2

Univ of Alabama at Birmingham - Pediatric

Birmingham, Alabama, United States, 35233

3

Long Beach Memorial (Pediatric)

Long Beach, California, United States, 90801

4

Los Angeles County - USC Med Ctr

Los Angeles, California, United States, 90033

A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children | DecenTrialz